General Update: Multiple articles on various major topics.
A shout-out to reader Gabi for her great research...
Breaking Free From Mass Formation with Mattias Desmet Click the photo to go to the audio podcast or video… (01:07:57)
Mattias Desmet is a Professor of Clinical Psychology at Ghent University in Belgium. His theory of mass formation during the Coronavirus crisis has become widely known and widely misunderstood since gaining mainstream attention.
His new book, The Psychology of Totalitarianism, lays out what mass formation is, how it develops, how it leads to totalitarianism, and what we must do to change the conditions that makes these mass formation events possible.
US Medical Company Sues Chinese Manufacturer Over 100,000+ Defective COVID-19 Tests with False Positive Results
A U.S. medical company is suing Chinese manufacturer Anhui DeepBlue who manufactured and distributed to the United States more than 100,000 defective antibody tests that showed false-positive results, according to American Military News.
AnyPlaceMD sued the Chinese medical technology company after two years “in an effort to recover nearly half a million dollars it lost buying defective tests.
According to the report, AnyPlaceMD has asked for a refund since 2020.
AnyPlaceMD provides state-of-the-art mobile and portable health care and specializes in Military Readiness by providing services to Government agencies such as the prison system, mental health centers, and rehabilitation services.
Please click on the image for a link to the article….
Confused between Sinovac and Sinopharm? What to know about their COVID-19 vaccines…
Chinese companies Sinovac and Sinopharm have been making headlines lately because of their respective COVID-19 vaccines.
And while they’re both leading Chinese vaccine makers and their names sound alike — beginning with the same Latin-derived prefix sino used to refer to China — they are different from each other.
Filipinos first heard about both companies mid-year when the government revealed that it approved collaborations with other countries for vaccine clinical trials.
Both have also consistently been on the top of the list of vaccine front-runners the World Health Organization has been monitoring.
As the country to be the first to detect the COVID-19 virus, China’s bio-pharmaceutical companies have been able to get ahead of the vaccine race.
However, both Sinovac and Sinopharm have also faced controversy — Sinovac for its bribery case and Sinopharm for supposedly being illegally used by the Presidential Security Group (PSG) of President Rodrigo Duterte.
So besides that, how does one tell the two companies apart? Here’s how they’re different:
OWNERSHIP
Sinopharm or the China National Pharmaceutical Group Corp. is a state-owned enterprise in China.
According to its website (reference: https://www.sinopharm.com/en/1398.html), the healthcare group has 128,000 employees and over 1,100 subsidiaries. It claims to be the world’s 6th largest vaccine manufacturer, producing all vaccines for China’s National Vaccination Program. Besides developing vaccines, it also distributes drugs and medical devices.
On the other hand, Sinovac is a private firm that has developed vaccines for influenza and hepatitis.
According to a Time article (reference: https://time.com/5872081/sinovac-covid19-coronavirus-vaccine-coronavac/), Sinovac was the only vaccine developer to reach Phase 1 clinical trials during the SARS outbreak in 2002 to 2003. It was that work that allowed the company to get a head start on their COVID-19 vaccine.
Please click on this image for a link to the article…
REVEALED: Fauci’s Recent, $10M Monkeypox Grant.
Gosh, what a surprise…
Anthony Fauci’s National Institutes of Health agency was funding research to identify treatments for Monkeypox shortly before the virus began spreading in a global outbreak.
Fauci’s agency, the National Institute of Allergy and Infectious Diseases (NIAID), has previously come under scrutiny for funding bat Coronavirus research at the Wuhan Institute of Virology, which many public health experts and intelligence officials believe to be the source of COVID-19.
NIAID has also funded research into potential cures for Monkeypox, shortly before the viral disease began spreading in a global outbreak.
The curious timing of the NIAID grant comes amidst pharmaceutical giants including Pfizer and Johnson & Johnson making record-level profits due to the COVID-19 pandemic.
The grant supports a “randomized, placebo-controlled trial of the safety and efficacy of Tecovirimat for the treatment of patients with Monkeypox virus disease.”
“The funding supports a clinical trial to identify effective treatments for Monkeypox virus disease,” explains a summary of the research, which, despite beginning in September 2020, has not generated any publicly available studies, papers, or patents.
Please click on the image for a link to the article…
Researcher: ‘We Made a Big Mistake’ on COVID-19 Vaccines
Research demonstrates a huge problem with all COVID-19 vaccines.
STORY AT-A-GLANCE
Canadian immunologist and vaccine researcher Byram Bridle, Ph.D., has gained access to Pfizer’s bio-distribution study from the Japanese regulatory agency. The research demonstrates a huge problem with all COVID-19 vaccines
The assumption that vaccine developers have been working with is that the mRNA in the vaccines would primarily remain in and around the vaccination site. Pfizer’s data, however, show the mRNA and subsequent spike protein are widely distributed in the body within hours
This is a serious problem, as the spike protein is a toxin shown to cause cardiovascular and neurological damage. It also has reproductive toxicity, and Pfizer’s bio-distribution data show it accumulates in women’s ovaries
Once in your blood circulation, the spike protein binds to platelet receptors and the cells that line your blood vessels. When that happens, it can cause platelets to clump together, resulting in blood clots, and/or cause abnormal bleeding
Pfizer documents submitted to the European Medicines Agency also show the company failed to follow industry-standard quality management practices during pre-clinical toxicology studies and that key studies did not meet good laboratory practice standards
The more we learn about the COVID-19 vaccines, the worse they look. In a recent interview[1] with Alex Pierson (above), Canadian immunologist and vaccine researcher Byram Bridle, Ph.D., dropped a shocking truth bomb that immediately went viral, despite being censored by Google.